COLGATE TOTAL Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Colgate Total, and when can generic versions of Colgate Total launch?

Colgate Total is a drug marketed by Colgate Palmolive and is included in one NDA.

The generic ingredient in COLGATE TOTAL is sodium fluoride; triclosan. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium fluoride; triclosan profile page.

Summary for COLGATE TOTAL

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	4
Clinical Trials:	30
Patent Applications:	413
Formulation / Manufacturing:	see details
DailyMed Link:	COLGATE TOTAL at DailyMed

Drug patent expirations by year for COLGATE TOTAL

Recent Clinical Trials for COLGATE TOTAL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Baghdad	Phase 3
University of California, San Francisco	Early Phase 1
Liverpool University Hospitals NHS Foundation Trust	Phase 4

See all COLGATE TOTAL clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for COLGATE TOTAL

US Patents and Regulatory Information for COLGATE TOTAL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for COLGATE TOTAL

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997	⤷ Try a Trial	⤷ Try a Trial
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997	⤷ Try a Trial	⤷ Try a Trial
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997	⤷ Try a Trial	⤷ Try a Trial
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997	⤷ Try a Trial	⤷ Try a Trial
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for COLGATE TOTAL

See the table below for patents covering COLGATE TOTAL around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
China	1057778		⤷ Try a Trial
Denmark	671289		⤷ Try a Trial
Austria	398034		⤷ Try a Trial
Czech Republic	8907511		⤷ Try a Trial
Taiwan	200401		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for COLGATE TOTAL

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1912999	1490062-5	Sweden	⤷ Try a Trial	PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
2932970	SPC/GB18/041	United Kingdom	⤷ Try a Trial	PRODUCT NAME: A COMBINATION COMPRISING DOLUTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF (E.G. DOLUTEGRAVIR SODIUM) AND RILPIVIRINE OR A PHARAMACEUTICALLY ACCEPTABLE SALT THEREOF (E.G. RILPIVIRINE HYDROCHLORIDE); REGISTERED: UK EU/1/18/1282 20180518; UK PLGB 35728/0055 20180518; UK PLGB 35728/0056 20180518; UK PLGB 35728/0057 20180518
2822954	LUC00083	Luxembourg	⤷ Try a Trial	PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM; AUTHORISATION NUMBER AND DATE: EU/1/18/1289 20180625
1856135	SPC/GB20/016	United Kingdom	⤷ Try a Trial	PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE, SOLVATE OR N-OXIDE OF FOSTAMATINIB OR THE PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REGISTERED: UK EU/1/19/1405 (NI) 20200113; UK PLGB 12930/0022 20200113; UK PLGB 12930/0023 20200113
2203431	2015/009	Ireland	⤷ Try a Trial	PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REGISTRATION NO/DATE: EU/1/14/983 20150115
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Summary for COLGATE TOTAL

Recent Clinical Trials for COLGATE TOTAL

Anatomical Therapeutic Chemical (ATC) Classes for COLGATE TOTAL

Make Better Decisions: Try a trial or see plans & pricing